Piperacillin induced bone marrow suppression: a case report
- PMID: 12791166
- PMCID: PMC165417
- DOI: 10.1186/1472-6904-3-2
Piperacillin induced bone marrow suppression: a case report
Abstract
Background: Piperacillin (and piperacillin/tazobactam) is a commonly prescribed antibiotic and is generally considered safe. We report a case of piperacillin induced bone marrow suppression.
Case presentation: A 19-year-old boy was being treated with piperacillin followed by piperacillin/tazobactam for infected pancreatic pseudocyst. After 21 days of treatment, he developed neutropenia and thrombocytopenia. These reversed promptly after stopping piperacillin/tazobactam. The time course of events suggested that piperacillin was the cause of bone marrow suppression in this patient.
Conclusion: Bone marrow suppression is a serious adverse effect of piperacillin, which should be kept in mind while treating patients with this drug.
Similar articles
-
Severe bone marrow suppression and hepatic dysfunction caused by piperacillin/tazobactam.Scand J Infect Dis. 2013 Nov;45(11):885-7. doi: 10.3109/00365548.2013.805426. Epub 2013 Jul 5. Scand J Infect Dis. 2013. PMID: 23826789
-
Piperacillin-induced thrombocytopenia reversed by high-flux hemodialysis in an uremic patient.Hemodial Int. 2012 Oct;16 Suppl 1:S50-3. doi: 10.1111/j.1542-4758.2012.00745.x. Hemodial Int. 2012. PMID: 23036037
-
Piperacillin and vancomycin induced severe thrombocytopenia in a hospitalized patient.Platelets. 2011;22(4):294-301. doi: 10.3109/09537104.2010.549973. Epub 2011 Feb 10. Platelets. 2011. PMID: 21309645
-
Hematologic adverse effects induced by piperacillin-tazobactam: a systematic review of case reports.Int J Clin Pharm. 2020 Aug;42(4):1026-1035. doi: 10.1007/s11096-020-01071-8. Epub 2020 Jun 4. Int J Clin Pharm. 2020. PMID: 32500262
-
Piperacillin-induced immune hemolysis: new cases and a concise review of the literature.Transfusion. 2010 May;50(5):1135-8. doi: 10.1111/j.1537-2995.2009.02544.x. Epub 2009 Dec 29. Transfusion. 2010. PMID: 20051057 Review.
Cited by
-
Piperacillin/tazobactam Induced Myelosuppression.J Clin Med Res. 2009 Apr;1(1):53-5. doi: 10.4021/jocmr2009.03.1227. Epub 2009 Mar 24. J Clin Med Res. 2009. PMID: 22505967 Free PMC article.
-
Drug-induced thrombocytopenia: a population study.Drug Saf. 2006;29(8):713-21. doi: 10.2165/00002018-200629080-00008. Drug Saf. 2006. PMID: 16872245
-
Hematologic Adverse Effects of Prolonged Piperacillin-Tazobactam Use in Adults.Turk J Haematol. 2018 Nov 13;35(4):290-295. doi: 10.4274/tjh.2018.0127. Epub 2018 Jun 1. Turk J Haematol. 2018. PMID: 29856362 Free PMC article.
-
Probable Vancomycin Induced Neutropenia: A Case Report.Cureus. 2019 Jul 22;11(7):e5199. doi: 10.7759/cureus.5199. Cureus. 2019. PMID: 31565605 Free PMC article.
-
A case of probable piperacillin/tazobactam-induced bone marrow suppression in a pregnant woman.Eur J Hosp Pharm. 2019 May;26(3):170-172. doi: 10.1136/ejhpharm-2017-001243. Epub 2017 Oct 21. Eur J Hosp Pharm. 2019. PMID: 31428326 Free PMC article.
References
-
- Kaucers A, Crowe SM, Grayson ML, Hoy JF, ed . Oxford: Butterworth Heinemann. 5 1997. The use of antibiotics: A clinical review of antibacterial, antifungal and antiviral drugs.
-
- Winston DJ, Murphy W, Young LS, Hewitt WL. Piperacillin therapy for serious bacterial infections. Am J Med. 1980;69:255–261. - PubMed
-
- Bressler RB, Huston DP. Piperacillin-induced anemia and leukopenia. South Med J. 1986;79:255–256. - PubMed
-
- Kirkwood CF, Lasezkay GM. Neutropenia associated with mezlocillin and piperacillin. Drug Intell Clin Pharm. 1985;19:112–114. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical